OnKure Therapeutics, Inc. Class A Common Stock

OKURNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
4.31 USD
↗ 0.02 (0.47%)🟢PRE MARKET (AS OF 07:21 PM EDT)
🟢Market: OPEN

Shares of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) are trading at $4.31. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, OKUR appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 17, 2026.

Open?$4.29
High?$4.48
Low?$4.00
Prev. Close?$4.29
Volume?298.2K
Avg. Volume?265.8K
VWAP?$4.31
Rel. Volume?1.12x
Bid / Ask
Bid?$3.63 × 100
Ask?$4.88 × 100
Spread?$1.25
Midpoint?$4.26
Valuation & Ratios
Market Cap?173.3M
Shares Out?40.4M
Float?9.8M
Float %?71.8%
P/E Ratio?N/A
P/B Ratio?0.94
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
45
Market Cap
173.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.onkuretherapeutics.com
Listed
2024-10-07
Address
6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO 80301
Phone: (720) 307-2892
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
99
Momentum?
77
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?5.72Safe
Confidence?36%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.39%Low
Short Interest?234.9K
Days to Cover?1.1
Free Float9.8M
Avg Daily Volume216.2K
Settlement Date2026-05-29
Financial Health
Current Ratio?13.78Strong
Quick Ratio?13.78Strong
Cash Ratio?13.41Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.94CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-31.9%WEAK▾
ROA?
S&P
3
-29.6%WEAK▾
Cash Flow & Enterprise
FCF?$-50794000
Enterprise Value?$-18809391
Fundamentals ratios updated end of day
MarketsMoversWatchlist